coronavirus treatment

Marshall University is studying whether an activated charcoal regimen can help coronavirus patients

One day after U.S. regulators canceled a trial for Eli Lilly’s experimental antibody treatment for being “unlikely to help” severe coronavirus patients, U.S. officials approved a $375 million deal for 300,000 doses of the same drug.

U.S. regulators have ended one of Eli Lilly’s COVID-19 antibody trials early after data suggested the drug was “unlikely to help” coronavirus patients recover.

The World Health Organization released the findings of their coronavirus therapeutics study on Friday, which studied the impact of drugs like remdesivir and hydroxychloroquine on treating hospitalized coronavirus patients.

Eli Lilly’s late-stage trial of its monoclonal antibody coronavirus treatment was paused by U.S. regulators over potential safety concerns.

President Donald Trump briefly left Walter Reed Medical Center in his motorcade to salute at supporters outside the hospital. Trump was admitted to Walter Reed for COVID treatment on Friday. Doctors have said the president is doing “well” and could return to the White House as early as Monday.

Doctors treating President Donald Trump for the coronavirus at Walter Reed Medical Center gave updates on the president’s treatment on Saturday morning. “At this time, the team and I are extremely happy with the progress the president has made,” said the president’s physician, Dr. Sean Conley.

With 74-year-old President Trump and 50-year-old first lady Melania Trump testing positive for the coronavirus, what are the best proven treatments for them and other patients?

The nearly 1 million people who have lost their lives to COVID-19 also have given the world a gift: a better understanding of how to treat the disease

Pharmaceutical giant Gilead says it plans to charge at least $2,300 for a single treatment course of Remdesivir, a drug shown to shorten recovery time for severely ill coronavirus patients.

A new study out of the University of Minnesota suggests that anti-malarial drug hydroxychloroquine has no effect on preventing patients from contracting the novel coronavirus.

Results from a phase three trial show that Remdesivir helps recovery in moderately-ill coronavirus patients.

At a press conference on Monday, Admiral Brett Giroir, assistant secretary for health, confirmed that HHS is working with a network of children’s hospitals and intensive care units to better understand the extreme coronavirus symptoms in infected children.

When asked if he takes responsibility for the spike in calls to poison control centers around the country following his on-camera comments about bleach and disinfectant injection as a potential coronavirus treatment, President Donald Trump said, “I can’t imagine why.”

Several D.C. hospitals are taking part in an experimental treatment that could be a lifesaver for critical COVID-19 patients. MedStar Georgetown University Hospital and MedStar Washington Hospital Center are part of a clinical trial sponsored by the Mayo Clinic. It’s called convalescent plasma therapy, injecting antibodies from coronavirus survivors into patients who are still fighting the virus at the...

Several D.C. hospitals are taking part in an experimental treatment that could be a lifesaver for critical COVID-19 patients. News4’s Doreen Gentzler reports.

Singer Jon Bon Jovi paid a digital visit this week to a kindergarten class, where he helped students strengthen their songwriting skills.

As patients with COVID-19 continue pouring into emergency departments and intensive care units across the nation, an old treatment that has been adapted for a new disease is now being tested in New York, NBC News reports.